COVID-19 patients from this cohort presented increased CRP as well as ALT and GGT levels, a reduced international normalised ratio and lower albumin concentrations, indicating impaired hepatic synthesis function, whereas bilirubin was normal [18]. The gene discussed is CRP; the disease is COVID-19.